Physical Activity and Sedentary Behavior in Patients with Systemic Lupus Erythematosus

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2018 Mar 6

PMID 29505598

Citations 24

Authors

Domenico Paolo Emanuele Margiotta

Fabio Basta

Giulio Dolcini

Veronica Batani

Marina Lo Vullo

Alessia Vernuccio

Luca Navarini

Antonella Afeltra

Affiliations

Soon will be listed here.

Abstract

Introduction: The aim of this study was to evaluate the proportion of patients with Systemic Lupus Erythematosus (SLE) who did not met the WHO recommendations for physical activity and to evaluate the amount of time spent in sedentary behavior.

Methods: SLE patients were consecutively enrolled in a cross sectional study. The type and the time spent in physical activity and sedentary behavior were evaluated using the IPAQ short form questionnaire. The adequate physical activity was defined according to the 2010 WHO recommendations for health and the sedentary behavior according to the 2017 SBRN consensus. We also assessed quality of life using SF-36, mood disorders using BDI and HAM-H, fatigue using Facit-Fatigue and sleep disorders using PSQI scores.

Results: Physical activity was not sufficient to meet WHO recommendations in 56 of 93 SLE patients (60%). SLE patients spent a median (95% range) of 180 (0-600) minutes everyday in sedentary activities. The length of daily sedentary time was more than 6 hours in 25% of SLE patients. In multivariable analysis, the factors associated to the probability of not meeting WHO criteria was only the time of exposure to antimalarials (OR 0.88, p 0.03) and the factors related to the probability of being in the upper tertile of sedentary time (more than 270 minutes) were age (OR 1.04, p 0.02), disease activity expressed by SELENA-SLEDAI score (OR 1.2, p 0.01) and Facit-fatigue score (OR 0.94, p 0.04).

Conclusion: A relevant proportion of SLE patients were inadequately physically active. It is essential to improve the awareness of the importance of increase physical activity and reduce sedentary time. A better control of disease activity and fatigue and a prolonged use of antimalarials could help to reach this notable goal.

Citing Articles

ActiLup: is it feasible? High-intensity interval training in systemic lupus erythematosus patients with fatigue: protocol for a prospective, monocentric proof-of-concept study.

Dreher M, Petros S, Engelhardt S, Geselle L, Baab J, Wicke T BMJ Open Sport Exerc Med. 2025; 11(1):e002403.

PMID: 39974335 PMC: 11836837. DOI: 10.1136/bmjsem-2024-002403.

Food consumption, physical activity and aerobic capacity in systemic lupus erythematosus patients with high cardiovascular risk.

Infante Smaira F, Caruso Mazzolani B, Mendes Sieczkowska S, Romero M, Ribeiro T, Amarante M Clinics (Sao Paulo). 2024; 79:100418.

PMID: 39003927 PMC: 11300905. DOI: 10.1016/j.clinsp.2024.100418.

Recommendations for physical activity and exercise in persons living with Systemic Lupus Erythematosus (SLE): consensus by an international task force.

Blaess J, Geneton S, Goepfert T, Appenzeller S, Bordier G, Davergne T RMD Open. 2024; 10(2).

PMID: 38580348 PMC: 11002419. DOI: 10.1136/rmdopen-2024-004171.

Maetzler W, Guedes L, Emmert K, Kudelka J, Hildesheim H, Paulides E Digit Biomark. 2024; 8(1):30-39.

PMID: 38510264 PMC: 10954320. DOI: 10.1159/000536568.

Regulatory Qualification of a Cross-Disease Digital Measure: Benefits and Challenges from the Perspective of IMI Consortium IDEA-FAST.

Nobbs D, Piwko W, Bull C, Cormack F, Ahmaniemi T, Holst S Digit Biomark. 2023; 7(1):132-138.

PMID: 37901363 PMC: 10601930. DOI: 10.1159/000533189.

References

Fasano S, Margiotta D, Navarini L, Pierro L, Pantano I, Riccardi A . Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review. Lupus. 2017; 26(14):1463-1472. DOI: 10.1177/0961203317722847. View

Ruiz-Arruza I, Ugarte A, Cabezas-Rodriguez I, Medina J, Moran M, Ruiz-Irastorza G . Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2014; 53(8):1470-6. DOI: 10.1093/rheumatology/keu148. View

Pancheri P, Picardi A, Pasquini M, Gaetano P, Biondi M . Psychopathological dimensions of depression: a factor study of the 17-item Hamilton depression rating scale in unipolar depressed outpatients. J Affect Disord. 2002; 68(1):41-7. DOI: 10.1016/s0165-0327(00)00328-1. View

Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M . The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996; 39(3):363-9. DOI: 10.1002/art.1780390303. View

Volkmann E, Grossman J, Sahakian L, Skaggs B, FitzGerald J, Ragavendra N . Low physical activity is associated with proinflammatory high-density lipoprotein and increased subclinical atherosclerosis in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2010; 62(2):258-65. PMC: 2853476. DOI: 10.1002/acr.20076. View

Pinto A, Miyake C, Benatti F, Silva C, Sallum A, Borba E . Reduced Aerobic Capacity and Quality of Life in Physically Inactive Patients With Systemic Lupus Erythematosus With Mild or Inactive Disease. Arthritis Care Res (Hoboken). 2016; 68(12):1780-1786. DOI: 10.1002/acr.22905. View

Petri M, Kim M, Kalunian K, Grossman J, Hahn B, Sammaritano L . Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005; 353(24):2550-8. DOI: 10.1056/NEJMoa051135. View

Biswas A, Alter D . Sedentary Time and Risk for Mortality. Ann Intern Med. 2015; 162(12):875-6. DOI: 10.7326/L15-5060-2. View

Vadacca M, Margiotta D, Navarini L, Afeltra A . Leptin in immuno-rheumatological diseases. Cell Mol Immunol. 2011; 8(3):203-12. PMC: 4012876. DOI: 10.1038/cmi.2010.75. View

10.

Ponticelli C, Moroni G . Hydroxychloroquine in systemic lupus erythematosus (SLE). Expert Opin Drug Saf. 2016; 16(3):411-419. DOI: 10.1080/14740338.2017.1269168. View

11.

Bombardier C, Gladman D, Urowitz M, Caron D, Chang C . Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992; 35(6):630-40. DOI: 10.1002/art.1780350606. View

12.

Ayan C, Martin V . Systemic lupus erythematosus and exercise. Lupus. 2007; 16(1):5-9. DOI: 10.1177/0961203306074795. View

13.

Vadacca M, Zardi E, Margiotta D, Rigon A, Cacciapaglia F, Arcarese L . Leptin, adiponectin and vascular stiffness parameters in women with systemic lupus erythematosus. Intern Emerg Med. 2011; 8(8):705-12. DOI: 10.1007/s11739-011-0726-0. View

14.

Ainsworth B, Bassett Jr D, Strath S, Swartz A, OBrien W, Thompson R . Comparison of three methods for measuring the time spent in physical activity. Med Sci Sports Exerc. 2000; 32(9 Suppl):S457-64. DOI: 10.1097/00005768-200009001-00004. View

15.

Alberti K, Zimmet P, Shaw J . The metabolic syndrome--a new worldwide definition. Lancet. 2005; 366(9491):1059-62. DOI: 10.1016/S0140-6736(05)67402-8. View

16.

Stamatakis E, Chau J, Pedisic Z, Bauman A, MacNiven R, Coombs N . Are sitting occupations associated with increased all-cause, cancer, and cardiovascular disease mortality risk? A pooled analysis of seven British population cohorts. PLoS One. 2013; 8(9):e73753. PMC: 3784430. DOI: 10.1371/journal.pone.0073753. View

17.

Katzmarzyk P . Physical activity, sedentary behavior, and health: paradigm paralysis or paradigm shift?. Diabetes. 2010; 59(11):2717-25. PMC: 2963526. DOI: 10.2337/db10-0822. View

18.

Kohl 3rd H, Craig C, Lambert E, Inoue S, Alkandari J, Leetongin G . The pandemic of physical inactivity: global action for public health. Lancet. 2012; 380(9838):294-305. DOI: 10.1016/S0140-6736(12)60898-8. View

19.

Giacomelli R, Afeltra A, Alunno A, Baldini C, Bartoloni-Bocci E, Berardicurti O . International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus,.... Autoimmun Rev. 2017; 16(9):911-924. DOI: 10.1016/j.autrev.2017.07.012. View

20.

Sharif K, Watad A, Bragazzi N, Lichtbroun M, Amital H, Shoenfeld Y . Physical activity and autoimmune diseases: Get moving and manage the disease. Autoimmun Rev. 2017; 17(1):53-72. DOI: 10.1016/j.autrev.2017.11.010. View